Actively Recruiting
Growth of Preterm Infants Fed a Infant Milk Formula Containing High Versus Low Amounts of Beta-palmitate
Led by Ospedali Riuniti Ancona · Updated on 2023-01-25
150
Participants Needed
2
Research Sites
254 weeks
Total Duration
On this page
Sponsors
O
Ospedali Riuniti Ancona
Lead Sponsor
I
Istituto di Ricerca Pediatrica Città della Speranza
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to assess weight gain of preterm infants (gestational age lower than 32 weeks) fed infant milk formula with about 60% beta-palmitate (EX\_IMF) vs infant milk formula with similar macronutrient, mineral and fatty acid composition but lower amounts of beta-palmitate (ST\_IMF). Own mother milk (OMM) fed infants will serve as reference group.
CONDITIONS
Official Title
Growth of Preterm Infants Fed a Infant Milk Formula Containing High Versus Low Amounts of Beta-palmitate
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Gestational age between 24 and 32 weeks at enrollment
- Birth weight greater than 750 grams
- Singleton or twin birth (no triplets or higher)
- Fraction of inspired oxygen lower than 0.60 at enrollment
- Feasible enteral feeding
- Cardiovascular stable condition
- Informed consent signed by at least one parent or legal guardian
You will not qualify if you...
- Congenital malformations, genetic, metabolic, or endocrine disorders
- Suspicious infection at enrollment
- Intrauterine growth restriction below the 10th centile at enrollment
- Maternal diabetes requiring insulin therapy
- Neonatal asphyxia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ospedali Riuniti di Ancona
Ancona, Italy, 60123
Actively Recruiting
2
Istituto di Ricerca Città della Speranza
Padua, Italy, 35127
Not Yet Recruiting
Research Team
V
Virgilio Carnielli, MD, PHD
CONTACT
A
Alessio Correani, MSc, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here